Cancer Cachexia Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Cancer Cachexia Therapeutics Market is segmented by therapeutics (Progestogen, Corticosteroid, Combination Therapy, and Other Therapeutics), mechanism of action (Appetite Stimulators and Weight Loss Stabilizers), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).

Cancer Cachexia Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cancer Cachexia Market Size

Cancer Cachexia Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 2.83 Billion
Market Size (2030) USD 3.48 Billion
CAGR (2025 - 2030) 4.19 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cancer Cachexia Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cancer Cachexia Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cancer Cachexia Market Analysis

The Cancer Cachexia Market size is estimated at USD 2.83 billion in 2025, and is expected to reach USD 3.48 billion by 2030, at a CAGR of 4.19% during the forecast period (2025-2030).

The COVID-19 outbreak impacted the Cancer Cachexia Market, as hospitals and healthcare services were significantly reduced due to social distancing measures enforced globally. The COVID-19 pandemic also affected the global economy and impacted general hospital care for non-COVID-19 patients in hospitals worldwide. According to a research article published in the British Journal of Nutrition, 2020, changes in nutritional status and weight loss during hospitalization are largely reported in some populations. However, it was not completely explored in COVID-19 patients. During the pandemic, the symptoms and associated conditions of COVID-19 deteriorated nutritional status, leading to Cancer Cachexia. Cancer patients were at a higher risk of being infected with COVID-19, as they are immunocompromised, and their ability to fight against the infection was very low compared to other individuals. Additionally, if a cancer patient developed a COVID-19 infection, there were higher chances of developing multiple organ-related complications or Cancer Cachexia. Hence, the COVID-19 pandemic affected the Cancer Cachexia Market significantly in its preliminary phase; however, currently the market is expected to have favorable growth in the forecast period as the COVID-19 has subsided.

The increasing prevalence of cancer and Cancer Cachexia cases and the increasing investment in the R&D activities for developing novel therapeutics in the treatment of Cancer Cachexia are the major factors driving the Cachexia Treatment Market.

The global cancer burden is increasing. Thus, cancer therapies must be modified according to regional and national priorities. According to the International Agency for Research on Cancer (IARC) in December 2020, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. According to the data published by WHO in February 2022, approximately 400,000 children develop cancer every year and the most common cancers vary between countries. Cervical cancer is the most common in 23 countries. Hence, the increasing burden of cancers worldwide also increases the prevalence of Cancer Wasting Syndrome among cancer patients, which is characterized by systemic inflammation, negative protein and energy balance, and an involuntary loss of lean body mass.

Due to this factor, most of the major players are focused on R&D activities to develop highly effective novel drugs in the treatment of Cancer Cachexia, leading to growth in the Cancer Cachexia Therapeutics Market. This factor resulted in an increased pipeline of Cancer Cachexia Therapeutics waiting for approval and commercial launch post-approval. For instance, clinicaltrials.gov reported that, as of October 2022, a total of 150 studies were conducted or were being conducted to develop drugs that treat Cancer Cachexia. In December 2020, a clinical study was initiated by University of Copenhagen, in collaboration with Zealand University Hospital, the study was conducted to monitor the effect of medical cannabidiol on lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy. Moreover, in January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received the manufacturing and marketing approval of Adlumiz in Japan. It is a ghrelin receptor agonist to treat Cancer Cachexia in malignant tumors of non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Hence, the increasing research and development activities for Cancer Cachexia are expected to drive the growth of the Cancer Cachexia Market.

However, manufacturers of Cancer Cachexia drugs are discouraged from investing in the Cancer Cachexia Therapeutics Market because of the strict regulatory requirements and the long FDA approval procedure, which may impede the long-term growth of this market.

Cancer Cachexia Industry Overview

The Cancer Supportive Care Market is consolidated in nature due to the presence of very few major companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Key market players include Aeterna Zentaris, Aphios Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Helsinn Group, Merck KGaA, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology, Aavogen Inc., Green Cross Wellbeing Corporation, Cannabics Pharmaceuticals Inc., TCI Peptide Therapeutics, Fresenius Kabi, Tetra Bio-Pharma, and Actimed Therapeutics among others, which are actively contributing to the Cancer Cachexia Therapeutics Market.

Cancer Cachexia Market Leaders

  1. Merck & Co. Inc.

  2. Aphios Corporation

  3. Helsinn Group

  4. Bristol-Myers Squibb Company

  5. Pfizer

  6. *Disclaimer: Major Players sorted in no particular order
Cancer Cachexia Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cancer Cachexia Market News

  • August 2022: ARTHEx biotech launched ENTRYTM , a platform that will allow it to advance its pipeline of drugs that includes drugs for myotonic dystrophy, cancer cachexia, and osteoarthritis by providing tissue-enriched delivery of antimiRs.
  • June 2022: The team led by Rutgers Cancer Institute of New Jersey received a USD 25 million Cancer Grand Challenges grant to research cancer cachexia, a debilitating condition people often experience in the later stages of their cancer.

Cancer Cachexia Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cancer Cachexia
    • 4.2.2 Strong R&D and Product Pipeline
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Requirements
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Therapeutics
    • 5.1.1 Progestogens
    • 5.1.2 Corticosteroids
    • 5.1.3 Combination Therapy
    • 5.1.4 Other Therapeutics
  • 5.2 By Mechanism of Action
    • 5.2.1 Appetite Stimulators
    • 5.2.2 Weight Loss Stabilizers
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aeterna Zentaris
    • 6.1.2 Aphios Corporation
    • 6.1.3 Bristol-Myers Squibb Company
    • 6.1.4 Pfizer Inc.
    • 6.1.5 Helsinn Group
    • 6.1.6 Merck KGaA
    • 6.1.7 Artelo Biosciences Inc.
    • 6.1.8 NGM Biopharmaceuticals
    • 6.1.9 Aveo Oncology
    • 6.1.10 Aavogen Inc.
    • 6.1.11 Green Cross Wellbeing Corporation
    • 6.1.12 Cannabics Pharmaceuticals Inc.
    • 6.1.13 TCI Peptide Therapeutics
    • 6.1.14 Fresenius Kabi
    • 6.1.15 Tetra Bio-Pharma
    • 6.1.16 Actimed Therapeutics
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cancer Cachexia Industry Segmentation

As per the scope of the report, cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia, and anemia. The pathogenicity of this syndrome is multifactorial due to a complex interaction of tumor and host factors. The signs and symptoms of cachexia are considered as the prognostic parameters in cancer patients. Cancer cachexia drugs are used to treat or alleviate the condition. The cancer cachexia market is segmented by therapeutics (progestogen, corticosteroid, combination therapy, and other therapeutics), mechanism of action (appetite stimulators and weight loss stabilizers), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Therapeutics Progestogens
Corticosteroids
Combination Therapy
Other Therapeutics
By Mechanism of Action Appetite Stimulators
Weight Loss Stabilizers
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cancer Cachexia Market Research FAQs

How big is the Cancer Cachexia Market?

The Cancer Cachexia Market size is expected to reach USD 2.83 billion in 2025 and grow at a CAGR of 4.19% to reach USD 3.48 billion by 2030.

What is the current Cancer Cachexia Market size?

In 2025, the Cancer Cachexia Market size is expected to reach USD 2.83 billion.

Who are the key players in Cancer Cachexia Market?

Merck & Co. Inc., Aphios Corporation, Helsinn Group, Bristol-Myers Squibb Company and Pfizer are the major companies operating in the Cancer Cachexia Market.

Which is the fastest growing region in Cancer Cachexia Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cancer Cachexia Market?

In 2025, the North America accounts for the largest market share in Cancer Cachexia Market.

What years does this Cancer Cachexia Market cover, and what was the market size in 2024?

In 2024, the Cancer Cachexia Market size was estimated at USD 2.71 billion. The report covers the Cancer Cachexia Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cancer Cachexia Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cancer Cachexia Industry Report

Statistics for the 2025 Cancer Cachexia market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cancer Cachexia analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.